Erratum: Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain (Translational Psychiatry, 4, e434(2014)) doi:10.1038/tp.2014.80);Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain

Translational Psychiatry

Volumn 4, Issue , 2014, Pages

  Basil, P ^a   Li, Q ^a   Dempster, E L ^b   Mill, J ^b,c   Sham, P C ^a   Wong, C C Y ^c   McAlonan, G M ^a,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GENOMIC DNA; METHYL CPG BINDING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DNA METHYLATION; DNA METHYLATION ASSAY; EPIGENETICS; FEMALE; GENETIC RISK; HYPOTHALAMUS; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; LONG INTERSPERSED ELEMENT 1; MALE; MATERNAL IMMUNE ACTIVATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; ONCOGENE; PRENATAL EXPOSURE; PROMOTER REGION; RETROPOSON; RISK FACTOR; SCHIZOPHRENIA; TRANSCRIPTION REGULATION; ADOLESCENT; BRAIN REGION; ENVIRONMENTAL EXPOSURE; GENETIC VARIABILITY; IMMUNOREGULATION; MATERNAL WELFARE; METHYLATION; PATHOPHYSIOLOGY; POST HOC ANALYSIS; PROGENY;

EID: 84907312153     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.104     Document Type: Erratum

References (79)

1. Waddington CH. The epigenotype. Int J Epidemiol 2012; 41: 10-13.
2. Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 2008; 9: 465-476. (Pubitemid 351693975)
3. Pidsley R, Dempster EL, Mill J. Brain weight in males is correlated with DNA methylation at IGF2. Mol Psychiatr 2010; 15: 880-881.
4. Nakahata Y, Grimaldi B, Sahar S, Hirayama J, Sassone-Corsi P. Signaling to the circadian clock: plasticity by chromatin remodeling. Curr Opin Cell Biol 2007; 19: 230-237. (Pubitemid 46386412)
5. Pidsley R, Mill J. Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry 2011; 69: 146-156.
6. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet 2011; 20: 4786-4796.
7. Wong CC, Meaburn EL, Ronald A, Price TS, Jeffries AR, Schalkwyk LC et al. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol Psychiatry 2013; 19: 495-503.
8. Murata M, Thanan R, Ma N, Kawanishi S. Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis. J Biomed Biotechnol 2012; 2012: 623019.
9. Li CC, Cropley JE, Cowley MJ, Preiss T, Martin DI, Suter CM. A sustained dietary change increases epigenetic variation in isogenic mice. PLoS Genet 2011; 7: e1001380.
10. Dominguez-Salas P, Cox SE, Prentice AM, Hennig BJ, Moore SE. Maternal nutritional status, C(1) metabolism and offspring DNA methylation: a review of current evidence in human subjects. Proc Nutr Soc 2012; 71: 154-165.
11. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308: 1466-1469. (Pubitemid 40791300)
12. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004; 61: 774-780. (Pubitemid 39031117)
13. Brown AS, Sourander A, Hinkka-Yli-Salomaki S, McKeague IW, Sundvall J, Surcel HM. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry 2013; 19: 259-264.
14. Parboosing R, Bao Y, Shen L, Schaefer CA, Brown AS. Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry 2013; 70: 677-685.
15. McAlonan GM, Li Q, Cheung C. The timing and specificity of prenatal immune risk factors for autism modeled in the mouse and relevance to schizophrenia. Neurosignals 2010; 18: 129-139.
16. Meyer U, Feldon J, Fatemi SH. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 2009; 33: 1061-1079.
17. Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S et al. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 2008; 99: 56-70.
18. Li Q, Cheung C, Wei R, Hui ES, Feldon J, Meyer U et al. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS ONE 2009; 4: e6354.
19. Meyer U, Feldon J, Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 2011; 69: 26r-33r.
20. Deng MY, Lam S, Meyer U, Feldon J, Li Q, Wei R et al. Frontal-subcortical protein expression following prenatal exposure to maternal inflammation. PLoS ONE 2011; 6: e16638.
21. Garbett KA, Hsiao EY, Kalman S, Patterson PH, Mirnics K. Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl Psychiatry 2012; 2: e98.
22. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 2008; 22: 469- 486.
23. Hodge DR, Xiao WH, Clausen PA, Heidecker G, Szyf M, Farrar WL. Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 2001; 276: 39508-39511.
24. Gasche JA, Hoffmann J, Boland CR, Goel A. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer 2011; 129: 1053-1063.
25. Muotri AR, Marchetto MCN, Coufal NG, Oefner R, Yeo G, Nakashima K et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010; 468: 443-446.
26. Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci USA 2005; 102: 12578-12583. (Pubitemid 41266401)
27. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008; 320: 1224-1229. (Pubitemid 351929512)
28. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23: 185-188. (Pubitemid 29455390)
29. Swanberg SE, Nagarajan RP, Peddada S, Yasui DH, LaSalle JM. Reciprocal coregulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. Hum Mol Genet 2009; 18: 525-534.
30. Wang L, Wang F, Guan J, Le J, Wu LH, Zou JZ et al. Relation between hypomethylation of long interspersed nucleotide elements and risk of neural tube defects. Am J Clin Nutr 2010; 91: 1359-1367.
31. Tate P, Skarnes W, Bird A. The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet 1996; 12: 205-208. (Pubitemid 26051304)
32. Thompson JL, Urban N, Slifstein M, Xu X, Kegeles LS, Girgis RR et al. Striatal dopamine release in schizophrenia comorbid with substance dependence. Mol Psychiatry 2013; 18: 909-915.
33. Langen M, Schnack HG, Nederveen H, Bos D, Lahuis BE, de Jonge MV et al. Changes in the developmental trajectories of striatum in autism. Biol Psychiatry 2009; 66: 327-333.
34. Goldstein JM, Seidman LJ, Makris N, Ahern T, O'Brien LM, Caviness VS Jr. et al. Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biol Psychiatry 2007; 61: 935-945. (Pubitemid 46505007)
35. Thompson JL, Pogue-Geile MF, Grace AA. Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms. Schizophr Bull 2004; 30: 875 -900.
36. Meyer U, Feldon J, Schedlowski M, Yee BK. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 2005; 29: 913-947. (Pubitemid 41097394)
37. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007; 445: 168-176. (Pubitemid 46095716)
38. Munoz-Lopez M, Macia A, Garcia-Canadas M, Badge RM, Garcia-Perez JL. An epi [c] genetic battle: LINE-1 retrotransposons and intragenomic conflict in humans. Mob Genet Elements 2011; 1: 122 -127.
39. Popp C, Dean W, Feng SH, Cokus SJ, Andrews S, Pellegrini M et al. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 2010; 463: 1101-U1126.
40. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002; 420: 520-562. (Pubitemid 35477048)
41. Hardies SC, Wang LP, Zhou LX, Zhao YP, Casavant NC, Huang SJ. LINE-1 (L1) lineages in the mouse. Mol Biol Evol 2000; 17: 616-628. (Pubitemid 30210706)
42. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921. (Pubitemid 32165345)
43. McCarthy EM, McDonald JF. Long terminal repeat retrotransposons of Mus musculus. Genome Biol 2004; 5: R14.
44. Kano H, Godoy I, Courtney C, Vetter MR, Gerton GL, Ostertag EM et al. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Gene Dev 2009; 23: 1303-1312.
45. Han JS, Szak ST, Boeke JD. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 2004; 429: 268-274. (Pubitemid 38684807)
46. Faulk C, Dolinoy DC. Timing is everything The when and how of environmentally induced changes in the epigenome of animals. Epigenetics 2011; 6: 791-797.
47. Muotri AR, Gage FH. Generation of neuronal variability and complexity. Nature 2006; 441: 1087-1093. (Pubitemid 43990721)
48. Bundo M, Toyoshima M, Okada Y, Akamatsu W, Ueda J, Nemoto-Miyauchi T et al. Increased L1 retrotransposition in the neuronal genome in schizophrenia. Neuron 2013; 81 : 306 -313.
49. Christensen J, Gronborg TK, Sorensen MJ, Schendel D, Parner ET, Pedersen LH et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013; 309: 1696- 1703.
50. Dong E, Chen Y, Gavin DP, Grayson DR, Guidotti A. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics-Us 2010; 5: 730-735.
51. Lueders KK, Kuff EL. Intracisternal A-particle genes: identification in the genome of Mus musculus and comparison of multiple isolates from a mouse gene library. Proc Natl Acad Sci USA 1980; 77: 3571-3575. (Pubitemid 10012277)
52. Gaubatz JW, Arcement B, Cutler RG. Gene-expression of an endogenous retrovirus-like element during murine development and aging. Mech Ageing Dev 1991; 57 : 71-85.
53. Jiao Y, Jin XD, Yan J, Jiao F, Li XM, Roe BA et al. An insertion of intracisternal A-particle retrotransposon in a novel member of the phosphoglycerate mutase family in the lew allele of mutant mice. Genes Genet Syst 2009; 84: 327 -334.
54. Faulk C, Barks A, Dolinoy DC. Phylogenetic and DNA methylation analysis reveal novel regions of variable methylation in the mouse IAP class of transposons. BMC Genomics 2013; 14: 48.
55. Wong EH, So HC, Li M, Wang Q, Butler AW, Paul B et al. Common variants on Xq28 conferring risk of schizophrenia in han Chinese. Schizophr Bull 2013; 40: 777-786.
56. LaSalle JM, Yasui DH. Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics 2009; 1: 119-130.
57. Ben-Shachar S, Chahrour M, Thaller C, Shaw CA, Zoghbi HY. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 2009; 18: 2431 -2442.
58. Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz-Picciotto I et al. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res 2008; 1: 169- 178.
59. Hsiao EY, Patterson PH. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 2011; 25: 604-615.
60. Dandrea M, Donadelli M, Costanzo C, Scarpa A, Palmieri M. MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. Nucleic Acids Res 2009; 37: 6681-6690.
61. Zhou ZL, Hong EJ, Cohen S, Zhao WN, Ho HYH, Schmidt L et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006; 52: 255-269. (Pubitemid 44548348)
62. Zhubi A, Chen Y, Dong E, Cook EH, Guidotti A, Grayson DR. Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum. Transl Psychiatry 2014; 4: e349.
63. Kundakovic M, Chen Y, Costa E, Grayson DR. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol 2007; 71: 644 -653.
64. Kimura H, Shiota K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J Biol Chem 2003; 278: 4806-4812. (Pubitemid 36800984)
65. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009; 37: D412-D416.
66. Gantz SC, Ford CP, Neve KA, Williams JT. Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway. J Neurosci 2011; 31: 12629-12637.
67. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005; 2: e141.
68. Hagberg B. Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand 1985; 74: 405-408. (Pubitemid 15034481)
69. Frieling H, Gozner A, Romer KD, Lenz B, Bonsch D, Wilhelm J et al. Global DNA hypomethylation and DNA hypermethylation of the alpha synuclein promoter in females with anorexia nervosa. Mol Psychiatr 2007; 12: 229-230. (Pubitemid 46328505)
70. Burghardt KJ, Pilsner JR, Bly MJ, Ellingrod VL. DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences. Epigenomics 2012; 4: 261-268.
71. Bierut LJ, Heath AC, Bucholz KK, Dinwiddie SH, Madden PAF, Statham DJ et al. Major depressive disorder in a community-based twin sample -Are there different genetic and environmental contributions for men and women? Arch Gen Psychiat 1999; 56: 557-563. (Pubitemid 29304652)
72. Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 2008; 4: 189-216. (Pubitemid 351668616)
73. Bauer M, Szulc J, Meyer M, Jensen CH, Terki TA, Meixner A et al. Delta-like 1 participates in the specification of ventral midbrain progenitor derived dopaminergic neurons. J Neurochem 2008; 104: 1101-1115. (Pubitemid 351146578)
74. Samaco RC, Mandel-Brehm C, Chao HT, Ward CS, Fyffe-Maricich SL, Ren J et al. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci USA 2009; 106: 21966 -21971.
75. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007; 128: 669-681. (Pubitemid 46273573)
76. Ziller MJ, Gu HC, Muller F, Donaghey J, Tsai LTY, Kohlbacher O et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 2013; 500: 477-481.
77. Maegawa S, Hinkal G, Kim HS, Shen LL, Zhang L, Zhang JX et al. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res 2010; 20: 332-340.
78. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012; 13: R14.
79. Avni R, Raz T, Biton IE, Kalchenko V, Garbow JR, Neeman M. Unique in utero identification of fetuses in multifetal mouse pregnancies by placental bidirectional arterial spin labeling MRI. Magn Reson Med 2012; 68: 560-570.